Sensei Biotherapeutics, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (3)
- Human Resources (20)
- Intellectual Property (1)
- Real Estate (1)
- Uncategorized (2)
- Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Josiah Craver, dated as of July 12, 2024 (Filed With SEC on November 14, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2024)
- Consulting Agreement, by and between Sensei Biotherapeutics, Inc. and Erin Colgan, dated as of April 11, 2024 (Filed With SEC on May 9, 2024)
- Amendment No. 1 to Services Agreement, by and between Sensei Biotherapeutics, Inc. and Monomy Advisors, LLC, dated May 7, 2024 (Filed With SEC on May 9, 2024)
- Second Amendment to Stockholder Rights Agreement, dated as of March 5, 2024, by and between Sensei Biotherapeutics, Inc. and Equiniti Trust Company, LLC, as rights agent (Filed With SEC on March 5, 2024)
- Employment Agreement, dated October 19, 2023, by and between the Registrant and Stephanie Krebs (Filed With SEC on February 29, 2024)
- Amendment to Rights Agreement, dated as of June 23, 2023, by and between Sensei Biotherapeutics, Inc. and American Stock Transfer & Trust Company, LLC, as rights agent (Filed With SEC on June 23, 2023)
- Purchase Agreement, dated May 23, 2023, by and among Sensei Biotherapeutics, Inc., on the one hand, and Apeiron Investment Group Ltd., Presight Sensei Co-Invest Fund, L.P.,... (Filed With SEC on May 23, 2023)
- Employment Agreement, dated May 5, 2022, by and between the Registrant and Patrick Gallagher (Filed With SEC on August 9, 2022)
- Description of Securities (incorporated by reference to Exhibit 4.3 to the Registrants Annual Report on Form 10-K (File No. 001-39980)) (Filed With SEC on March 15, 2022)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)
- Separation from Employment Letter and Separation Agreement, by and between Sensei Biotherapeutics, Inc. and Marie-Louise Fjaellskog, dated as of December 1, 2021 (Filed With SEC on March 15, 2022)
- First Amended and Restated Employment Agreement, dated April 28, 2021, by and between the Company and Erin Colgan (Filed With SEC on May 3, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
- Investors Rights Agreement, dated as of December 29, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on February 1, 2021)
- Form of warrant to purchase common stock (Filed With SEC on February 1, 2021)
- Form of warrant to purchase common stock (Filed With SEC on February 1, 2021)
- Form of warrant to purchase common stock (Filed With SEC on February 1, 2021)
- Sensei Biotherapeutics, Inc. 2021 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on February 1, 2021)
- Sensei Biotherapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and John Celebi, dated as of January 28, 2021 (Filed With SEC on February 1, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Marie-Louise Fjaellskog, dated as of January 28, 2021 (Filed With SEC on February 1, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Robert H. Pierce, dated as of January 28, 2021 (Filed With SEC on February 1, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Anupama Hoey, dated as of January 28, 2021 (Filed With SEC on February 1, 2021)
- Stock Purchase Agreement, by and among Sensei Biotherapeutics, Inc. and the stockholders of Alvaxa Biosciences, Inc., dated as of May 18, 2020 (Filed With SEC on January 15, 2021)
- Investors Rights Agreement, dated as of January 10, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on January 15, 2021)
- Sensei Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended, and forms of agreements thereunder (Filed With SEC on January 15, 2021)
- Non-exclusive License Agreement, by and between Alvaxa Biosciences, Incorporated and Fred Hutch Cancer Research Center, dated as of January 3, 2020 (Filed With SEC on January 15, 2021)
- Form of Indemnification Agreement entered into by and between Sensei Biotherapeutics, Inc. and each director and executive officer (Filed With SEC on January 15, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and John Celebi, dated as of January 1, 2021 (Filed With SEC on January 15, 2021)
- Amended and Restated Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Marie-Louise Fjaellskog, dated as of December 4, 2020 (Filed With SEC on January 15, 2021)
- Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Robert H Pierce, dated as of February 9, 2020 (Filed With SEC on January 15, 2021)
- Independent Contractor and Strategic Advisory Services Agreement entered into by and between Sensei Biotherapeutics, Inc. and Samuel Broder M.D., dated as of May 8, 2018, as... (Filed With SEC on January 15, 2021)
- Lease Agreement, by and between Sensei Biotherapeutics, Inc. and Are-Maryland No. 8 Corp., dated as of October 22, 2020 (Filed With SEC on January 15, 2021)
- Employment Agreement, by and between Sensei Biotherapeutics, Inc. and Anupama Hoey, dated as of October 13, 2020 (Filed With SEC on January 15, 2021)
